XML 28 R12.htm IDEA: XBRL DOCUMENT
v3.6.0.2

Intangible Assets | 12 Months Ended
--- | ---
Oct. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract] |
Intangible Assets | Intangible Assets Goodwill
(In millions) | CooperVision |  | CooperSurgical |  | Total
Balance as of October 31, 2014 | $ | 1,861.5 |  |  | $ | 359.4 |  |  | $ | 2,220.9 |
Net (reductions) additions during the year ended October 31, 2015 | (1.2 | ) |  | 17.4 |  |  | 16.2 |
Translation | (32.7 | ) |  | (7.3 | ) |  | (40.0 | )
Balance as of October 31, 2015 | $ | 1,827.6 |  |  | $ | 369.5 |  |  | $ | 2,197.1 |
Net additions during the year ended October 31, 2016 | 9.1 |  |  | 156.9 |  |  | 166.0 |
Translation | (190.3 | ) |  | (8.1 | ) |  | (198.4 | )
Balance as of October 31, 2016 | $ | 1,646.4 |  |  | $ | 518.3 |  |  | $ | 2,164.7 |
Of the October 31, 2016 goodwill balance, $117.9 million for CooperSurgical and $19.7 million for CooperVision is expected to be deductible for tax purposes. Other Intangible Assets
| As of October 31, 2016 |  | As of October 31, 2015 |  |
(In millions) | Gross Carrying Amount |  | Accumulated Amortization & Translation |  | Gross Carrying Amount |  | Accumulated Amortization & Translation |  | Weighted Average Amortization Period
|  |  |  |  |  |  |  |  | (In years)
Trademarks | $ | 36.6 |  |  | $ | 6.8 |  |  | $ | 23.7 |  |  | $ | 4.4 |  |  | 12
Technology | 354.8 |  |  | 139.3 |  |  | 318.9 |  |  | 114.7 |  |  | 11
Customer relationships | 285.7 |  |  | 121.9 |  |  | 247.0 |  |  | 104.5 |  |  | 13
License and distribution rights and other | 65.8 |  |  | 33.8 |  |  | 71.7 |  |  | 26.6 |  |  | 9
| 742.9 |  |  | $ | 301.8 |  |  | 661.3 |  |  | $ | 250.2 |  |  | 12
Less accumulated amortization and translation | 301.8 |  |  |  |  | 250.2 |  |  |  |  |
Other intangible assets, net | $ | 441.1 |  |  |  |  | $ | 411.1 |  |  |  |  |
Included in Technology at October 31, 2016, is $7.4 million of acquired in-process research and development from Sauflon that is not amortized. Included in Technology at October 31, 2015 is $39.5 million of acquired in-process research and development from Sauflon, of which $2.3 million was written off and $29.8 million has been placed in service in during fiscal 2016. See Note 2. Acquisitions for additional information on acquired intangible assets from Sauflon. We estimate that amortization expense for our existing other intangible assets will be approximately $58.5 million in fiscal 2017, $56.5 million in fiscal 2018, $54.2 million in fiscal 2019, $44.7 million in fiscal 2020 and $43.1 million in fiscal 2021.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for all or part of the information related to intangible assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275 + Details
Name: | us-gaap_IntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration